Trials / Completed
CompletedNCT05051982
Sedline EEG Guided Depth of Anesthesia
SedLine EEG-Guided Depth of Anesthesia: Effect of Anesthetic Dosage
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 110 (actual)
- Sponsor
- Indiana University · Academic / Other
- Sex
- All
- Age
- 65 Years
- Healthy volunteers
- Accepted
Summary
The purpose of our study is to determine if monitoring sedation (how asleep patients are under general anesthesia) using a device called a Sedline Monitor affects the amount of anesthesia patients receive.
Detailed description
The main objective of this study is to determine if monitoring sedation using the FDA approved device, Sedline Monitor, affects the amount of anesthesia patients 65 or older receive during surgery. Reducing the anesthetic dose could result in less exposure of anesthetic medications to a high-risk patient population as well as a potential reduction in cost. Subjects will be randomized into either a control group or study group and have the Sedline Monitor placed on their head before the start of their already scheduled surgery. During the surgery, subjects in the control group will receive standard anesthesia care and the study group will receive anesthetic drug doses guided by Sedline Monitor processed EEG characteristics. When the surgery is complete, the Sedline Monitor will be removed and subject participation will be finished. The study team will also collect information about subjects from their medical records and use it for this study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Sedline EEG in View | EEG monitor (Sedline) will be in full view of the Anesthesiologist during surgery. |
Timeline
- Start date
- 2021-06-30
- Primary completion
- 2022-11-14
- Completion
- 2022-11-14
- First posted
- 2021-09-21
- Last updated
- 2024-01-16
- Results posted
- 2024-01-16
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05051982. Inclusion in this directory is not an endorsement.